NME
ABBV icon

Notis-McConarty Edward’s AbbVie ABBV Stock Holding History

Notis-McConarty Edward’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.25M Sell
14,937
-250
-2% -$55.5K 1.61% 25
2025
Q4 		$3.47M Sell
15,187
-200
-1% -$45.6K 1.61% 24
2025
Q3 		$3.56M Sell
15,387
-200
-1% -$40.7K 1.66% 22
2025
Q2 		$2.89M Hold
15,587
– – 1.41% 26
2025
Q1 		$3.27M Sell
15,587
-308
-2% -$59.9K 1.68% 25
2024
Q4 		$2.82M Sell
15,895
-1,500
-9% -$276K 1.37% 26
2024
Q3 		$3.44M Sell
17,395
-6,775
-28% -$1.26M 1.55% 26
2024
Q2 		$4.15M Sell
24,170
-955
-4% -$158K 1.63% 24
2024
Q1 		$4.58M Sell
25,125
-3,320
-12% -$572K 1.81% 22
2023
Q4 		$4.41M Sell
28,445
-880
-3% -$128K 1.76% 22
2023
Q3 		$4.37M Sell
29,325
-250
-0.8% -$36.7K 1.78% 22
2023
Q2 		$3.98M Sell
29,575
-75
-0.3% -$11K 1.52% 25
2023
Q1 		$4.73M Sell
29,650
-150
-0.5% -$22.9K 1.88% 18
2022
Q4 		$4.82M Sell
29,800
-400
-1% -$61.3K 2.01% 18
2022
Q3 		$4.05M Sell
30,200
-1,000
-3% -$143K 1.81% 18
2022
Q2 		$4.78M Sell
31,200
-1,375
-4% -$210K 1.99% 17
2022
Q1 		$5.28M Sell
32,575
-2,410
-7% -$350K 1.88% 18
2021
Q4 		$4.74M Sell
34,985
-250
-0.7% -$29.5K 1.58% 22
2021
Q3 		$3.8M Sell
35,235
-115
-0.3% -$13.1K 1.39% 24
2021
Q2 		$3.98M Sell
35,350
-725
-2% -$81.7K 1.47% 25
2021
Q1 		$3.9M Sell
36,075
-675
-2% -$72.2K 1.52% 22
2020
Q4 		$3.94M Hold
36,750
– – 1.6% 22
2020
Q3 		$3.22M Buy
36,750
+150
+0.4% +$14.1K 1.42% 22
2020
Q2 		$3.59M Sell
36,600
-450
-1% -$39.6K 1.68% 20
2020
Q1 		$2.82M Sell
37,050
-50
-0.1% -$4.26K 1.56% 22
2019
Q4 		$3.28M Hold
37,100
– – 1.46% 24
2019
Q3 		$2.81M Hold
37,100
– – 1.32% 27
2019
Q2 		$2.7M Hold
37,100
– – 1.27% 28
2019
Q1 		$2.99M Sell
37,100
-100
-0.3% -$8.18K 1.44% 22
2018
Q4 		$3.43M Buy
37,200
+4,250
+13% +$374K 1.89% 21
2018
Q3 		$3.12M Hold
32,950
– – 1.67% 23
2018
Q2 		$3.05M Sell
32,950
-550
-2% -$53.7K 1.81% 23
2018
Q1 		$3.17M Sell
33,500
-800
-2% -$87.9K 1.9% 22
2017
Q4 		$3.32M Buy
34,300
+2,330
+7% +$220K 1.9% 21
2017
Q3 		$2.84M Sell
31,970
-1,250
-4% -$95.2K 1.78% 22
2017
Q2 		$2.41M Hold
33,220
– – 1.56% 23
2017
Q1 		$2.16M Sell
33,220
-1,691
-5% -$106K 1.42% 25
2016
Q4 		$2.19M Sell
34,911
-30
-0.1% -$1.83K 1.51% 23
2016
Q3 		$2.2M Sell
34,941
-100
-0.3% -$6.47K 1.51% 24
2016
Q2 		$2.17M Hold
35,041
– – 1.52% 24
2016
Q1 		$2M Sell
35,041
-2,385
-6% -$133K 1.42% 25
2015
Q4 		$2.22M Sell
37,426
-1,015
-3% -$58.5K 1.59% 23
2015
Q3 		$2.09M Sell
38,441
-3,280
-8% -$214K 1.56% 23
2015
Q2 		$2.8M Buy
41,721
+1,616
+4% +$105K 1.9% 17
2015
Q1 		$2.35M Hold
40,105
– – 1.63% 25
2014
Q4 		$2.62M Hold
40,105
– – 1.79% 19
2014
Q3 		$2.32M Sell
40,105
-10,800
-21% -$600K 1.63% 23
2014
Q2 		$2.87M Hold
50,905
– – 1.9% 17
2014
Q1 		$2.62M Sell
50,905
-200
-0.4% -$10.1K 1.82% 19
2013
Q4 		$2.7M Buy
+51,105
New +$2.51M 1.89% 18

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Notis-McConarty Edward's ABBV Position: Q1 2026 in Review

Notis-McConarty Edward reduced its AbbVie (ABBV) stake by 1.6% in Q1 2026, selling an estimated $55.5K and leaving 14,937 shares worth $3.25M. The position accounts for 1.61% of the portfolio, ranked #25.

Notis-McConarty Edward first reported a position in ABBV in Q4 2013 and has held it in 50 quarters since. The position peaked at $5.28M in Q1 2022. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Notis-McConarty Edward held 14,937 shares of AbbVie worth $3.25M as of Q1 2026.
  • Notis-McConarty Edward sold 250 AbbVie shares in Q1 2026, an estimated $55.5K.
  • AbbVie made up 1.61% of Notis-McConarty Edward's portfolio in Q1 2026, its #25 holding.
  • Notis-McConarty Edward first reported a position in AbbVie in Q4 2013 and has held it in 50 quarters since.
  • Notis-McConarty Edward's AbbVie position peaked at $5.28M in Q1 2022.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Notis-McConarty Edward's 13F filing for Q1 2026, filed 8 May 2026.